About the Laboratory Center

The ARLG Laboratory Center Director is Robin Patel, MD, Mayo Clinic, with Sarah Doernberg, MD, MAS, University of California San Francisco serving as the Associate Director and Kerryl Greenwood-Quaintance, MS serving as the ARLG Laboratory Center Program Manager.

Robin Patel, MD Mayo Clinic
Robin Patel, MD, Mayo Clinic
Sarah Doernberg, MD, MAS University of California San Francisco
Sarah Doernberg, MD, MAS University of California San Francisco
Kerryl Greenwood-Quaintance, MS, Mayo Clinic
Kerryl Greenwood-Quaintance, MS, Mayo Clinic

The ARLG Laboratory Consortium Team includes Barry Kreiswirth, PhD, Rutgers University; Ritu Banerjee, MD, PhD, Vanderbilt University; and Patricia Simner, Ph.D, M.Sc, Johns Hopkins University.

Also affiliated with the Laboratory Center are Cesar Arias, MD, PhD., Houston Methodist Hospital; Thomas Lodise, PharmD, PhD, Albany College of Pharmacy and Health Sciences; Kimberly Hanson, MD, University of Utah; Melinda Pettigrew, PhD, Yale University; and Robert Bonomo, MD, Case Western Reserve University.

Barry Kreiswirth, PhD
Barry Kreiswirth, PhD
Ritu Banerjee, MD, PhD
Ritu Banerjee, MD, PhD
Patricia Simner, Ph.D., M.Sc.
Patricia Simner, Ph.D., M.Sc.
Cesar Arias, MD, PhD
Cesar Arias, MD, PhD
Thomas Lodise, PharmD
Thomas Lodise, PharmD
Kimberly Hanson, MD
Kimberly Hanson, MD
Melinda Pettigrew, PhD
Melinda Pettigrew, PhD
Robert Bonomo, MD
Robert Bonomo, MD

Mission

The mission of the ARLG Laboratory Center is to facilitate and support the ARLG scientific agenda by:

  • Leading the assessment, development, and implementation of laboratory-based ARLG studies, and addressing laboratory needs of non-laboratory-based ARLG studies, by providing expertise, coordinating laboratory services, and offering supervision of ARLG-affiliated laboratories.

  • Conducting laboratory-based studies using the Master Protocol for Evaluating Multiple Infection Diagnostics (MASTERMIND) initiative for researching multiple diagnostics on a single patient sample.

  • Executing outcomes-based clinical studies based on diagnostics.

  • Performing phenotypic and genotypic characterization of ARLG study isolates.

  • Managing the ARLG Biorepository's collection of isolates and making them available to the research community (including industry) through a web-based catalog.

  • Developing GENO-SMART, a web tool that uses genomic data to predict phenotypic antimicrobial susceptibility.

  • Providing consultative services to scientists in academia and industry, e.g. assisting with questions related to laboratory testing.

  • Assisting the ARLG Mentoring Committee in mentoring new investigators.

Contact the Lab Center

To facilitate and support the ARLG research agenda by leading the development, implementation, and evaluation of the laboratory research.

Biorepository Goal

To provide scientists with access to gram-positive and -negative bacteria for development of novel diagnostic tests, assessment of new antimicrobial approaches, and/or use in research studies (e.g., evaluating mechanisms of resistance or novel therapeutics).